The government of Australia has administered 3,3 million doses of the AstraZeneca vaccine, and it has been linked to 60 cases of blood clots.
"This updated advice received today is based on new evidence demonstrating a higher risk for the very rare (thrombocytopenia syndrome) condition in the 50-59-year-old age group," Hunt said.
Hunt said the recommendation would not delay its inoculation timetable, which has a target of giving at least one COVID-19 vaccine dose to every Australian before the end of 2021.
In April, Australia recommended people under 50 should get Pfizer's COVID-19 vaccine in preference to AstraZeneca's shot. Australia's Chief Medical Officer, Paul Kelly said Australia will advise healthcare professionals to administer only the first dose of AstraZeneca to adults under the age of 50 when the benefits clearly outweigh the risks.
As it was reported earlier, the export of the AstraZeneca vaccine to Australia is banned by the EU and the Italian government. The ban is caused by the fail of AstraZeneca manufacturer to provide a sufficient amount of doses to the EU countries.